Baseline geriatric vulnerabilities and QOL scores are associated with survival after chemotherapy in older adults with metastatic pancreatic cancer, researchers found.

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...

The same mRNA technology behind COVID-19 vaccines is now being used in the fight against cancer, and the University of ...

Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...

The addition of high-dose IV vitamin C to standard chemotherapy nearly doubled OS for patients with advanced pancreatic cancer, according to results of a randomized phase 2 trial.Vitamin C also ...

Silexion Therapeutics (SLXN) announced new preclinical data for SIL-204, its next-generation siRNA therapeutic candidate. The findings ...

Revolution Medicines' promising KRAS inhibitors show potential in pancreatic cancer. See why we recommend a hold rating on ...

Extensive research shows that drinking alcohol increases the risk of cancer, and U.S. public-health ... finance reporter for MarketWatch based in New York City. She previously covered business ...

Biomarker testing is often used to help connect a patient with the right treatment at the right time. After a cancer ...

SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...

Radiation oncologists at UH Seidman Cancer Center have another powerful treatment option for patients diagnosed with many forms of cancer with the addition of Varian Ethos 2.0, capable of a new form ...